Geneviève Laureys

机构：Ghent University Hospital, Ghent University · ORCID：0000-0002-5302-4298

发表论文 343 篇 · 总被引 11154 次 · h-index 54

代表论文

• Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1) (2021 · Journal of Clinical Oncology · 被引 82)
• Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study (2021 · Journal of Clinical Oncology · 被引 77)
• Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study (2020 · Epigenetics · 被引 71)
• BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial. (2022 · Journal of Clinical Oncology · 被引 35)
• The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples (2021 · European Journal of Cancer · 被引 29)
• Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial (2024 · Journal of Clinical Oncology · 被引 27)